BIO-B Stock 12 Month Analyst Forecast
Eps Overview
Growth Next 5yrs
N/A
Last Quarter
$2.26
Past Year
-
Growth Past 5yrs
N/A
Next Quarter
-
Estimate Next Year
-
Consensus Rating
Loading...
Consensus Price Target
Highest Price Target
N/A
0% Upside
Mean Price Target
N/A
0% Upside
Lowest Price Target
N/A
0% Upside
Recent Analyst Ratings
Upgrades, Downgrades, New Coverage
Actual EPS vs Estimated EPS
BIO-B Earnings Per Share (EPS) History
According to financial reports, BIO-B (NYSE: BIO-B) reported an actual EPS of $2.26 for the quarter ending on Oct 29, 2025, compared to an estimated $1.89, resulting in a 19.58% surprise. In the prior quarter (Aug 04, 2025), BIO-B recorded an actual EPS of $11.67 with a 566.86% surprise. See BIO-B's full earnings history.
Earnings History
EPS Surprise Factor Analysis
BIO-B has experienced notable EPS surprises, with the latest quarter ending Oct 29, 2025 showing a 19.58% beat. Previously, the quarter ending Aug 04, 2025 recorded a 566.86% beat. An EPS surprise factor indicates how much actual earnings deviate from analyst forecasts.
| Report Date | Actual | Forecast | Surprise Factor |
|---|---|---|---|
| Oct 29, 2025 | 2.26 | 1.89 | +19.58% |
| Aug 04, 2025 | 11.67 | 1.75 | +566.86% |
| Jul 31, 2025 | 11.67 | 1.75 | +566.86% |
| May 01, 2025 | 2.29 | 1.82 | +25.82% |
| Feb 13, 2025 | -25.56703 | 2.86 | -993.95% |
| Oct 30, 2024 | 23.34 | 1.13 | +1,965.49% |
Frequently Asked Questions
Is BIO-B stock getting favorable reviews from Wall Street analysts?
Brokerage firms have given BIO-B stock an average recommendation of
N/A. 0 analysts have given their ratings
to BIO-B out of which
0 analysts have given strong buy call,
0 analysts have given buy call,
0 analysts rate it hold,
0 analysts advocate strong sell call, and
0 analysts has given sell rating. The average target price of
- gives the stock implied downside
of roughly 0% over the next year or so.
What have analysts suggested for BIO-B highest price target?
Analysts suggest BIO-B's stock price would rise to a high of -.
What is the lowest price target analysts expect for BIO-B over the next year?
Within the next 12 months, analysts predict the BIO-B stock price could move to -.
What is the average target price for BIO-B?
BIO-B stock has an average analyst estimate of -.
At its current price, how far is BIO-B from its average target price?
BIO-B shares are currently trading 0% below this price target.
What were BIO-B’s actual earnings per share for the recent quarter?
Its quarterly earnings per share (EPS) came in at $2.26 versus consensus estimates of $1.89, and above the comparable year-ago quarter’s EPS of - $25.57.
What are the current estimates for quarterly and annual earnings per share?
BIO-B's forecasts by analysts estimating quarterly EPS at - and - for the whole year.
What has BIO-B's growth been in the past five years and what is expected in the next five years?
The analysts have projected N/A EPS growth for BIO-B in the next five years, compared to growth rates of N/A in the past five years.